Salomon Z. Langer
Director/Board Member at Mindset BioPharmaceuticals Ltd.
Profile
Salomon Z.
Langer is a Director of Mindset BioPharmaceuticals Ltd.
and Vice President of Molecular Biology and Drug Discovery for Compugen Ltd.
He is President of the Latin American Society of Pharmacology, Vice President of the Collegium Internationale Neuro-Psychopharmacologicum, and a Professor of the University of Buenos Aires.
Previously, Dr. Langer was President of Research and Development for Synthelabo SA and Head of the Department of Pharmacology for the Wellcome Research Laboratories.
Salomon Z. Langer active positions
| Companies | Position | Start |
|---|---|---|
Mindset BioPharmaceuticals Ltd.
 Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
| Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | - |
Former positions of Salomon Z. Langer
| Companies | Position | End |
|---|---|---|
Synthélabo SA
 Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Corporate Officer/Principal | - |
| Wellcome Research Laboratories | Corporate Officer/Principal | - |
| Universidad de Buenos Aires | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Health Services |
| Collegium Internationale Neuro-Psychopharmacologicum | |
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Health Technology |
| Wellcome Research Laboratories |
- Stock Market
- Insiders
- Salomon Z. Langer
